Episode 46: ASCO 2023 - Early Lung Cancer

Written By Inquisitive Oncology

In this episode, Michael and Josh investigate Lung Oncology research presented at ASCO 23, specifically early lung cancer treatment. They discuss Perioperative Toripalimab, LAG3 inhibitor Relatlimab and the new novel agent BI 764532, a novel DLL3-targeting T cell engaged.


Inquisitive Oncology
Previous

Episode 47: ASCO 2023 - Colorectal Cancer
Next

Episode 45: ASCO 2023 - Gynaecologic Cancers